Huntington's disease: degradation of mutant huntingtin by autophagy

被引:159
|
作者
Sarkar, Sovan [1 ]
Rubinsztein, David C. [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
autophagy; Huntington's disease; lithium; mTOR; polyglutamine; rapamycin;
D O I
10.1111/j.1742-4658.2008.06562.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autophagy is a nonspecific bulk degradation pathway for long-lived cytoplasmic proteins, protein complexes, or damaged organelles. This process is also a major degradation pathway for many aggregate-prone, disease-causing proteins associated with neurodegenerative disorders, such as mutant huntingtin in Huntington's disease. In this review, we discuss factors regulating the degradation of mutant huntingtin by autophagy. We also report the growing list of new drugs/pathways that upregulate autophagy to enhance the clearance of this mutant protein, as autophagy upregulation may be a tractable strategy for the treatment of Huntington's disease.
引用
收藏
页码:4263 / 4270
页数:8
相关论文
共 50 条
  • [1] Autophagy in Huntington disease and huntingtin in autophagy
    Martin, Dale D. O.
    Ladha, Safia
    Ehrnhoefer, Dagmar E.
    Hayden, Michael R.
    TRENDS IN NEUROSCIENCES, 2015, 38 (01) : 26 - 35
  • [2] Mutant huntingtin-impaired degradation of β-catenin causes neurotoxicity in Huntington's disease
    Godin, Juliette D.
    Poizat, Ghislaine
    Hickey, Miriam A.
    Maschat, Florence
    Humbert, Sandrine
    EMBO JOURNAL, 2010, 29 (14): : 2433 - 2445
  • [3] Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington’s disease patients
    Karolina Pierzynowska
    Lidia Gaffke
    Zuzanna Cyske
    Grzegorz Węgrzyn
    Metabolic Brain Disease, 2019, 34 : 715 - 720
  • [4] Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients
    Pierzynowska, Karolina
    Gaffke, Lidia
    Cyske, Zuzanna
    Wegrzyn, Grzegorz
    METABOLIC BRAIN DISEASE, 2019, 34 (03) : 715 - 720
  • [5] QUANTIFYING MUTANT HUNTINGTIN IN HUNTINGTON'S DISEASE CSF
    Wild, Edward
    Robertson, Nicola
    Miller, James
    Traeger, Ulrike
    Haider, Salman
    Macdonald, Douglas
    Langbehn, Douglas
    Kuhn, Rainer
    Weiss, Andreas
    Tabrizi, Sarah
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [6] Lowering Mutant Huntingtin Levels and Toxicity: Autophagy-Endolysosome Pathways in Huntington's Disease
    Valionyte, Evelina
    Yang, Yi
    Roberts, Sheridan L.
    Kelly, Jack
    Lu, Boxun
    Luo, Shouqing
    JOURNAL OF MOLECULAR BIOLOGY, 2020, 432 (08) : 2673 - 2691
  • [7] Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease
    Ehrnhoefer, Dagmar E.
    Martin, Dale D. O.
    Schmidt, Mandi E.
    Qiu, Xiaofan
    Ladha, Safia
    Caron, Nicholas S.
    Skotte, Niels H.
    Nguyen, Yen T. N.
    Vaid, Kuljeet
    Southwell, Amber L.
    Engemann, Sabine
    Franciosi, Sonia
    Hayden, Michael R.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6 : 16
  • [8] Glutamine Synthetase 1 Increases Autophagy Lysosomal Degradation of Mutant Huntingtin Aggregates in Neurons, Ameliorating Motility in a Drosophila Model for Huntington's Disease
    Vernizzi, Luisa
    Paiardi, Chiara
    Licata, Giusimaria
    Vitali, Teresa
    Santarelli, Stefania
    Raneli, Martino
    Manelli, Vera
    Rizzetto, Manuela
    Gioria, Mariarosa
    Pasini, Maria E.
    Grifoni, Daniela
    Vanoni, Maria A.
    Gellera, Cinzia
    Taroni, Franco
    Bellosta, Paola
    CELLS, 2020, 9 (01)
  • [9] Stimulation of autophagy by genistein reduces levels of mutant huntingtin in cellular models of Huntington disease
    Pierzynowska, Karolina
    Mantej, Jagoda
    Niedzialek, Natalia
    Hac, Aleksandra
    Wegrzyn, Grzegorz
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S107 - S107
  • [10] Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease
    Dagmar E. Ehrnhoefer
    Dale D. O. Martin
    Mandi E. Schmidt
    Xiaofan Qiu
    Safia Ladha
    Nicholas S. Caron
    Niels H. Skotte
    Yen T. N. Nguyen
    Kuljeet Vaid
    Amber L. Southwell
    Sabine Engemann
    Sonia Franciosi
    Michael R. Hayden
    Acta Neuropathologica Communications, 6